Le Lézard
Classified in: Health, Business
Subject: TNM

Biomerics Acquires FutureMatrix Interventional


SALT LAKE CITY, June 4, 2018 /PRNewswire/ -- Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc.  FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urinary markets.   

New Logo for Biomerics FMI

"We are pleased to add FMI's capabilities to the Biomerics portfolio," stated Travis Sessions, CEO.  "We welcome the FMI team to the group, and look forward to their contribution.  This acquisition expands our capabilities and important customer relationships.  We look forward to investing in and expanding the business for our customers, employees, and community.  Combining FMI with Biomerics' existing medical device business establishes Biomerics as a leader in the attractive minimally invasive interventional segment of the medical device market".

FMI, founded in 1993 by James Passmore, started by developing PTA catheters. Over the years, the company expanded its PTA balloon technologies and developed other peripheral cardiovascular, kidney stone management, and urinary catheters.  Today, the FDA registered location includes over 50,000 sq. ft. of manufacturing space and employs more than 400 employees.

Biomerics, with over 1000 employees, operates seven facilities located in Utah, Minnesota, Indiana, Costa Rica, and Texas.  Founded in 2009, Biomerics has grown into a market leader in the minimally invasive interventional catheter market.  Biomerics provides engineered components to the medical device market including biomaterials, extrusions, molded parts, laser processed parts, machined parts, balloons, and reinforced shafts.  Additionally, it supplies packaged sterile medical devices including advanced interventional catheters, surgical tools, and vascular access products. 

About Biomerics

Biomerics specializes in the design, development, and production of medical devices for diagnostic and interventional procedures for the cardiovascular, structural heart, cardiac rhythm management, and vascular access markets. The company, formed in 2009, provides a full range of engineered components and finished devices to the world's leading medical device OEMs.   

SOURCE Biomerics, LLC


These press releases may also interest you

at 04:25
Ademi LLP is investigating Doma  for possible breaches of fiduciary duty and other violations of law in its transaction with Title Resources Group. ...

at 04:00
U Power Limited (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that the Company held an extraordinary general meeting of...

at 04:00
Tonight on BBC1, REMY founder Abeer Iqbal, entered the Den, and despite intense grilling and no investment, left with a six-figure job offer from Peter Jones. ...

at 04:00
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or "the Company") and certain of its officers....

at 03:57
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of those who held the common stock of Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company as of the record date of March...

at 03:44
Bitrue, a leading cryptocurrency exchange serving over 10 million users globally, announces a focus on user behavior analysis to further develop the utility of its native token, Bitrue Coin (BTR). "Understanding how our users interact with BTR is...



News published on and distributed by: